ESC Premium Access

Novel thromboelastography point-of-care test detects all commercially available DOACs at therapeutic concentrations and classifies them as direct thrombin or factor Xa inhibitors with high consistency

Congress Presentation

About the speaker

Doctor Hardean Achneck

Haemonetics Corporation, Braintree (United States of America)
0 follower

3 more presentations in this session

Balancing bleeding risk and effectiveness in patients requiring oral anticoagulation - State of the art

Speaker: Professor P. Kirchhof (Hamburg, DE)

Thumbnail

Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

How to best predict bleeding risk: clinical or biological tests?

Speaker: Professor R. Kiss (Budapest, HU)

Thumbnail

Access the full session

Bleeding risk and oral anticoagulation

Speakers: Doctor H. Achneck, Professor P. Kirchhof, Doctor M. Proietti, Professor R. Kiss
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk